All In Biotech

Drug Trial Radar · NCT07128797

a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease(NAFLD)

A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Phase Ib Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Subcutaneous Injections of B1344 Injection in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

Last checked: Nov 20, 2026Latest source record: Aug 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

32

Planned (sponsor's estimate)

Start

Jul 24, 2025

Primary completion

Jun 2026

Study completion Jul 2026

Sponsor

Sponsor type
Industry
First posted
Aug 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, multicenter, placebo-controlled, multiple-dose escalating clinical trial designed to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity profile of B1344 in patients with NAFLD. Additionally, the trial will conduct preliminary observations on the efficacy of B1344, aiming to provide early proof of concept for B1344 as a therapeutic agent for NASH.

Conditions

  • NAFLD (Non-alcoholic Fatty Liver Disease)
  • NASH (Nonalcoholic Steatohepatitis)

Interventions

  • B1344Drug

    Subcutaneous injection

  • PlaceboOther

    Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency and severity of Adverse Events (AEs) and Serious Adverse EventsTime frame: 113 days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University

    Beijing, Beijing Municipality, China · Recruiting

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Sinopharm Tongmei General Hospital

    Datong, Shanxi, China · Not yet recruiting

  • The First Affiliated Hospital to Nankai University

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • The First Affiliated Hospital to Wenzhou Medical University

    Wenzhou, Zhejiang, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.